Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy

S. K. Kumar, J. Mikhael, B. Laplant, M. Q. Lacy, F. K. Buadi, D. Dingli, M. A. Gertz, K. Laumann, T. Miceli, M. Mahlman, L. P. Bergsagel, S. R. Hayman, C. Reeder, A. K. Stewart, A. Dispenzieri, D. A. Gastineau, J. L. Winters

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences